I am pleased to let you know that ANVISA have now officially passed a resolution to suspend the deadlines for Brazilian pharmaceutical serialisation requirements in RDC54. There are, therefore, no residual Brazil serialisation deadlines pending.
This means that the small residual risk that these requirements would be enforced has gone away and we can all look forward to the new law and its more realistic timelines being published in November.
Should you have any questions about this or any other of my blogs, or would simply like to request a copy of my booklets, please don’t hesitate to contact me at Stephen.McIndoe@be4ward.com.
For more information on serialisation, go to our free download section.